Metformin Hydrochloride Oral Solution
Metformin Hydrochloride is used to treat type two diabetes.
Metformin Hydrochloride Oral Solution is indicated for:
Treatment of type 2 diabetes mellitus, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control.
In adults, Metformin Hydrochloride Oral Solution may be used as monotherapy or in combination with other oral anti-diabetic agents or with insulin.
In children from 10 years of age and adolescents, Metformin Hydrochloride Oral Solution may be used as monotherapy or in combination with insulin.
A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure (see 5.1. On the EMC for Pharmacodynamic properties).
Summary of Product Characteristics
Read this summary of product characteristics for further information about Metformin Hydrochloride Oral Solution. Click below to navigate to the EMC.
Patient Information Leaflet
Read this patient information leaflet about Metformin Hydrochloride Oral Solution, what it’s used for and possible side effects. Click below to navigate to the EMC.
Metformin Hydrochloride Oral Solution
Click here for Audio Version | |
Flavour | Peach and Peppermint |
Storage Conditions | Store in refrigerator under 2-8°C |
Sucrose Free | |
Shelf Life (Closed Bottle/Open Bottle) | 12 Months / 28 days |
PIP Code | 115-5068 |
EAN Code | 05016119000089 |
Sodium Levels | Essentially sodium-free |
Ethanol Concentration | None |
Downloads
Click here for Audio Version | |
Flavour | Peach and Peppermint |
Storage Conditions | Store in refrigerator under 2-8°C |
Sucrose Free | |
Shelf Life (Closed Bottle/Open Bottle) | 12 months / 28 days |
PIP Code | 113-6167 |
EAN Code | 05016119000171 |
Sodium Levels | Essentially sodium-free |
Ethanol Concentration | None |
Downloads
Adverse Events
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk
Adverse events should also be reported to Rosemont at 0113 244 1400 or pharmacovigilance@rosemontpharma.com.
Contact us
For further product information and pricing please use the form below and a member of the team will be in touch
Stay updated via our App
A new Rosemont Pharmaceuticals App for Healthcare Professionals is launching soon.